| Item Type | Name |
|
Academic Article
|
Phosphoproteomic analysis of the human pathogen Trypanosoma cruzi at the epimastigote stage.
|
|
Academic Article
|
Global analysis of protein palmitoylation in African trypanosomes.
|
|
Academic Article
|
Visual genome-wide RNAi screening to identify human host factors required for Trypanosoma cruzi infection.
|
|
Academic Article
|
SUMOylation pathway in Trypanosoma cruzi: functional characterization and proteomic analysis of target proteins.
|
|
Academic Article
|
Improved proteomic approach for the discovery of potential vaccine targets in Trypanosoma cruzi.
|
|
Academic Article
|
Proteomic analysis of Trypanosoma cruzi secretome: characterization of two populations of extracellular vesicles and soluble proteins.
|
|
Academic Article
|
Potential use of synthetic a-galactosyl-containing glycotopes of the parasite Trypanosoma cruzi as diagnostic antigens for Chagas disease.
|
|
Academic Article
|
Characterization of the small RNA content of Trypanosoma cruzi extracellular vesicles.
|
|
Academic Article
|
A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease.
|
|
Academic Article
|
Structural and functional analysis of a platelet-activating lysophosphatidylcholine of Trypanosoma cruzi.
|
|
Academic Article
|
Molecular characterization of Trypanosoma cruzi SAP proteins with host-cell lysosome exocytosis-inducing activity required for parasite invasion.
|
|
Academic Article
|
Molecular Characterization of a Novel Family of Trypanosoma cruzi Surface Membrane Proteins (TcSMP) Involved in Mammalian Host Cell Invasion.
|
|
Academic Article
|
Validation of N-myristoyltransferase as Potential Chemotherapeutic Target in Mammal-Dwelling Stages of Trypanosoma cruzi.
|
|
Academic Article
|
Purification of Glycosylphosphatidylinositol-Anchored Mucins from Trypanosoma cruzi Trypomastigotes and Synthesis of a-Gal-Containing Neoglycoproteins: Application as Biomarkers for Reliable Diagnosis and Early Assessment of Chemotherapeutic Outcomes of Chagas Disease.
|
|
Academic Article
|
A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage.
|
|
Academic Article
|
The surface coat of the mammal-dwelling infective trypomastigote stage of Trypanosoma cruzi is formed by highly diverse immunogenic mucins.
|
|
Academic Article
|
Trypanosoma cruzi oleate desaturase: molecular characterization and comparative analysis in other trypanosomatids.
|
|
Academic Article
|
Short report: benznidazole efficacy among Trypanosoma cruzi-infected adolescents after a six-year follow-up.
|
|
Academic Article
|
Trypanosoma cruzi histone H1 is phosphorylated in a typical cyclin dependent kinase site accordingly to the cell cycle.
|
|
Academic Article
|
Cooperative activation of TLR2 and bradykinin B2 receptor is required for induction of type 1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi.
|
|
Academic Article
|
Trypanosoma cruzi: involvement of glycoinositolphospholipids in the attachment to the luminal midgut surface of Rhodnius prolixus.
|
|
Academic Article
|
Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholine.
|
|
Academic Article
|
GPIomics: global analysis of glycosylphosphatidylinositol-anchored molecules of Trypanosoma cruzi.
|
|
Academic Article
|
Proteomic analysis of detergent-solubilized membrane proteins from insect-developmental forms of Trypanosoma cruzi.
|
|
Academic Article
|
Inconclusive results in conventional serological screening for Chagas' disease in blood banks: evaluation of cellular and humoral response.
|
|
Concept
|
Trypanosoma
|
|
Concept
|
Trypanosoma brucei brucei
|
|
Concept
|
Trypanosoma congolense
|
|
Concept
|
Trypanosoma cruzi
|
|
Concept
|
Variant Surface Glycoproteins, Trypanosoma
|
|
Concept
|
Trypanosoma brucei rhodesiense
|
|
Academic Article
|
Macrophage signaling by glycosylphosphatidylinositol-anchored mucin-like glycoproteins derived from Trypanosoma cruzi trypomastigotes.
|
|
Academic Article
|
Platelet-activating factor-like activity isolated from Trypanosoma cruzi.
|
|
Academic Article
|
Trypanosoma congolense procyclins: unmasking cryptic major surface glycoproteins in procyclic forms.
|
|
Academic Article
|
Sphingolipid synthesis is necessary for kinetoplast segregation and cytokinesis in Trypanosoma brucei.
|
|
Academic Article
|
Enhanced nitrosative stress during Trypanosoma cruzi infection causes nitrotyrosine modification of host proteins: implications in Chagas' disease.
|
|
Academic Article
|
Subcellular proteomics of Trypanosoma cruzi reservosomes.
|
|
Academic Article
|
Redundancy of proteins in the salivary glands of Panstrongylus megistus secures prolonged procurement for blood meals.
|
|
Academic Article
|
Trypanosoma cruzi epimastigotes are able to store and mobilize high amounts of cholesterol in reservosome lipid inclusions.
|
|
Academic Article
|
Intraspecies variation in Trypanosoma cruzi GPI-mucins: biological activities and differential expression of a-galactosyl residues.
|
|
Academic Article
|
Evaluation of a recombinant Trypanosoma cruzi mucin-like antigen for serodiagnosis of Chagas' disease.
|
|
Academic Article
|
Evaluation of a chemiluminescent enzyme-linked immunosorbent assay for the diagnosis of Trypanosoma cruzi infection in a nonendemic setting.
|
|
Academic Article
|
Synthesis of Gala(1,3)Gal?(1,4)GlcNAca-, Gal?(1,4)GlcNAca- and GlcNAc-containing neoglycoproteins and their immunological evaluation in the context of Chagas disease.
|
|
Academic Article
|
Virus-like Particle Display of the a-Gal Epitope for the Diagnostic Assessment of Chagas Disease.
|
|
Academic Article
|
Extracellular Vesicles from Trypanosoma brucei Mediate Virulence Factor Transfer and Cause Host Anemia.
|
|
Academic Article
|
Sterol targeting drugs reveal life cycle stage-specific differences in trypanosome lipid rafts.
|
|
Academic Article
|
Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.
|
|
Academic Article
|
Trypanosoma cruzi-Infected Human Macrophages Shed Proinflammatory Extracellular Vesicles That Enhance Host-Cell Invasion via Toll-Like Receptor 2.
|
|
Academic Article
|
Plasma-Derived Extracellular Vesicles as Potential Biomarkers in Heart Transplant Patient with Chronic Chagas Disease.
|
|
Academic Article
|
Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy.
|
|
Academic Article
|
Sheltered in Stromal Tissue Cells, Trypanosoma cruzi Orchestrates Inflammatory Neovascularization via Activation of the Mast Cell Chymase Pathway.
|
|
Academic Article
|
A Branched and Double Alpha-Gal-Bearing Synthetic Neoglycoprotein as a Biomarker for Chagas Disease.
|
|
Academic Article
|
Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy.
|
|
Academic Article
|
The Trypanosoma brucei MISP family of invariant proteins is co-expressed with BARP as triple helical bundle structures on the surface of salivary gland forms, but is dispensable for parasite development within the tsetse vector.
|
|
Academic Article
|
Fatty acid elongases 1-3 have distinct roles in mitochondrial function, growth, and lipid homeostasis in Trypanosoma cruzi.
|